ATE74126T1 - D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. - Google Patents

D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Info

Publication number
ATE74126T1
ATE74126T1 AT88300710T AT88300710T ATE74126T1 AT E74126 T1 ATE74126 T1 AT E74126T1 AT 88300710 T AT88300710 T AT 88300710T AT 88300710 T AT88300710 T AT 88300710T AT E74126 T1 ATE74126 T1 AT E74126T1
Authority
AT
Austria
Prior art keywords
prostaglandins
tranquilizers
hypnotics
applications
soporifics
Prior art date
Application number
AT88300710T
Other languages
English (en)
Inventor
Ryuzo Ueno
Ryuji Ueno
Ichie Kato
Tomio Oda
Original Assignee
Ueno Seiyaku Oyo Kenkyujo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo Kk filed Critical Ueno Seiyaku Oyo Kenkyujo Kk
Application granted granted Critical
Publication of ATE74126T1 publication Critical patent/ATE74126T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT88300710T 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum. ATE74126T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1882187 1987-01-28
EP88300710A EP0281239B1 (de) 1987-01-28 1988-01-28 D-Prostaglandine und ihre Anwendung in Tranquilizern und Hypnotikum

Publications (1)

Publication Number Publication Date
ATE74126T1 true ATE74126T1 (de) 1992-04-15

Family

ID=11982228

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88300710T ATE74126T1 (de) 1987-01-28 1988-01-28 D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.

Country Status (8)

Country Link
US (3) US5073569A (de)
EP (1) EP0281239B1 (de)
KR (1) KR930006201B1 (de)
AT (1) ATE74126T1 (de)
CA (1) CA1322749C (de)
DE (1) DE3869444D1 (de)
ES (1) ES2032956T3 (de)
GR (1) GR3004281T3 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212200A (en) * 1987-09-18 1993-05-18 R-Tech Ueno, Ltd. Ocular hypotensive agents
US6420422B1 (en) 1987-09-18 2002-07-16 Sucampo Pharmaceuticals, Inc. Ocular hypotensive agents
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
JP2597629B2 (ja) 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
JP2721414B2 (ja) * 1988-09-06 1998-03-04 フアーマシア・アンド・アツプジヨン・アー・ベー 縁内障または眼圧亢進の治療のためのプロスタグランジン誘導体
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
ATE122563T1 (de) * 1989-07-27 1995-06-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von 15-keto-prostansäure-derivaten zur herstellung eines medikaments für die verbesserung der ausscheidung des kaliumions.
US5234954A (en) * 1989-07-27 1993-08-10 K.K. Ueno Seiyaku Oyo Kenkyujo Treatment of hyperlipidemia with 15-keto-prostaglandin compounds
ATE121624T1 (de) * 1989-08-09 1995-05-15 Ueno Seiyaku Oyo Kenkyujo Kk Verwendung von prostansäurederivaten zur herstellung von arzneimitteln zur verbesserung der ausscheidung von nichtprotein in die därme.
CA2027814C (en) * 1989-10-20 1996-07-30 Ryuji Ueno Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
CA2030345C (en) * 1989-11-22 1998-12-08 Ryuji Ueno Use of 15-keto-prostaglandin compound for improvement of encephalic function
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
TW249226B (de) * 1990-04-04 1995-06-11 Aderk Ueno Kk
CA2046069C (en) * 1990-07-10 2002-04-09 Ryuji Ueno Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
ATE141794T1 (de) * 1991-03-14 1996-09-15 R Tech Ueno Ltd Stimulierung von wundheilung mit 15-keto- prostaglandinverbindungen
DK1083168T3 (da) 1998-05-25 2003-12-15 Taisho Pharmaceutical Co Ltd Prostaglandinderivat
AR030275A1 (es) 2000-03-24 2003-08-20 Sucampo Pharmaceuticals Inc Composicion que inhibe la apoptosis y uso de un compuesto 15-ceto-prostaglandina- para producirla
DE60139002D1 (de) * 2000-04-06 2009-07-30 Sucampo Ag Gallensäurefördernde zusammensetzung für lebertransplantation welche ein 15-keto prostaglandin enthält
TWI302100B (en) 2001-05-02 2008-10-21 Sucampo Ag Composition for treating drug-induced constipation
AU2002330747B2 (en) 2001-08-31 2007-07-19 Sucampo Ag Prostaglandin analogs as chloride channel opener
WO2005018646A1 (ja) 2003-08-21 2005-03-03 Sucampo Ag 眼科用組成物
ES2379652T3 (es) * 2002-10-23 2012-04-30 Sucampo Ag Compuestos de prostaglandina para el tratamiento de obesidad
CN1753680B (zh) 2002-12-27 2010-12-08 苏坎波公司 用于治疗腹部不适的前列腺素衍生物
WO2005002588A1 (en) * 2003-07-03 2005-01-13 Sucampo Ag Enteric coated composition comprising prostaglandin analogs as chloride channel opener
TWI495471B (zh) * 2003-08-12 2015-08-11 R Tech Ueno Ltd 促進毛髮生長之組成物及方法
US7321057B2 (en) * 2004-08-02 2008-01-22 R-Tech Ueno, Ltd. Method for manufacturing prostaglandin analogue
DK1841433T3 (da) 2005-01-27 2012-01-16 Sucampo Ag Præparat til behandling af lidelser i centralnervesystemet
ATE489955T1 (de) 2005-03-04 2010-12-15 Sucampo Ag Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten
US20060281818A1 (en) 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
AU2006234632B2 (en) * 2005-04-12 2011-10-27 Sucampo Ag Combined use of prostaglandin compound and proton pump inhibitor for the treatment of gastrointestinal disorders
CA2637274C (en) 2006-01-24 2013-06-04 R-Tech Ueno, Ltd. Soft-gelatin capsule formulation
NZ570190A (en) * 2006-01-24 2011-03-31 Sucampo Ag Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound
CN103768070A (zh) * 2006-03-13 2014-05-07 株式会社·R-技术上野 水性组合物
US8871752B2 (en) * 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US8609729B2 (en) 2009-04-15 2013-12-17 Sucampo Ag Method for treating macular degeneration
US8569279B2 (en) * 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
US9084815B2 (en) * 2009-09-16 2015-07-21 Sucampo Ag Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor
EP2694077A4 (de) 2011-04-07 2015-01-21 Sucampo Ag Verfahren zur behandlung von asthenopie
RU2648474C2 (ru) 2011-08-05 2018-03-26 Сукампо Аг Способ лечения шизофрении
AR092821A1 (es) 2012-04-20 2015-05-06 Sucampo Ag Conjugado de derivado de acido graso-polimero
US20150057351A1 (en) 2013-08-22 2015-02-26 Sucampo Ag Method for treating neuropathic pain
AR105029A1 (es) 2015-06-19 2017-08-30 Sucampo Ag Composición farmacéutica que comprende derivado de ácido graso

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1476661A (en) * 1974-05-13 1977-06-16 American Cyanamid Co Prostaglandins
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.

Also Published As

Publication number Publication date
EP0281239A2 (de) 1988-09-07
ES2032956T3 (es) 1993-03-01
KR880008986A (ko) 1988-09-13
CA1322749C (en) 1993-10-05
KR930006201B1 (ko) 1993-07-08
US5137915A (en) 1992-08-11
US5073569A (en) 1991-12-17
GR3004281T3 (de) 1993-03-31
EP0281239B1 (de) 1992-03-25
DE3869444D1 (de) 1992-04-30
US5534547A (en) 1996-07-09
EP0281239A3 (en) 1988-09-21

Similar Documents

Publication Publication Date Title
ATE74126T1 (de) D-prostaglandine und ihre anwendung in tranquilizern und hypnotikum.
DE3871751D1 (de) Gelbildende organosiloxanzusammensetzungen und deren verwendung.
DE69009636D1 (de) Belastungsregelung und Verfahren.
DE3853191D1 (de) Arzneimittelträger.
DE3884095D1 (de) Polymerteilchen und ihre Herstellung.
DE3851132D1 (de) Polymerteilchen und ihre Herstellung.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
DE3789761D1 (de) Reibungsmaterialien und Herstellung derselben.
DE3853340D1 (de) Dien-Blockpolymer und Polymerzusammensetzung.
ATE82574T1 (de) Bis-aza-bicyclische anxiolytica und antidepressiva.
DE3880893D1 (de) Fluessige modifizierte statistische aethylencopolymere und ihre verwendung.
DE3888146D1 (de) Modifizierte Polytetrafluoräthylenharze und damit hergestellte Zusammensetzungen.
DE3767400D1 (de) Biozide zusammensetzungen und deren verwendung.
DE69010141D1 (de) Lager und Lageranordnung.
DE3873797D1 (de) E-prostaglandine und ihre anti-ulcusanwendung.
DE3679896D1 (de) Schmiermittelzusammensetzung und verwendung davon.
DE68917352D1 (de) Trimethylolheptane und ihre Anwendung.
DE3882727D1 (de) Mycoplasma-membran-antigene und ihre verwendung.
DE69002520D1 (de) Azeotropaehnliche zusammensetzungen von 1,1-dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1-fluoraethan.
PT85396A (de) Neue 1,4-benzodiazepine ihre herstellung und verwendung
DE3766441D1 (de) Anilinotriazine und deren verwendung.
DE69012298D1 (de) Heizen von Lagern und dergleichen.
ES2044100T4 (es) Ciertas combinaciones de antagonistas del "paf" y antihistaminicos y metodos.
DE59003130D1 (de) Mikrobizid-Formulierungen und deren Verwendung.
DE69012929D1 (de) Phosphitverbindung und deren anwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee